Dynavax Technologies Corporation has announced changes to its management team. David F. Novack will transition from President and Chief Operating Officer to Senior Vice President and Chief Operating Officer, effective January 1, 2026. Robert Janssen, M.D. will step down from his roles as Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs by March 2, 2026, or upon the appointment of a new Chief Medical Officer. The company has begun searching for Dr. Janssen's successor.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavax Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-240766), on October 16, 2025, and is solely responsible for the information contained therein.